Top Ten: Weekend roundup: Nike’s good fit with Kaepernick | Apple’s new product cycle |Next financial crisis

This post was originally published on this site

MarketWatch rounds up 10 of its most interesting topics over the past week.

1. Nike does perfectly well with Kaepernick

On Sept. 4, after Nike NKE, +0.57%  announced that Colin Kaepernick would be the face of its 30th anniversary “Just do It” advertising campaign, shares of Nike decline 3% for the day, causing a typical slew of inflammatory headlines. But a price decline on any given day may reflect the action of a very small minority of investors, and a 3% decline doesn’t mean much in the context of Nike shares already up 31% for 2018.

Indeed, Nike’s stock price soon returned to record levels. The real story is an increase in sales for the company and plenty of love from analysts:

Nike’s online sales jumped 31% after company unveiled Kaepernick campaign, data show

Nike upgraded in face of Colin Kaepernick advertising controversy

Nike stock price target hiked at Wedbush as analyst cheers ‘resurgent iconic American, global brand’

Foot Locker shares rise after it’s upgraded on boost from Nike

Here’s what Twitter data say about the Nike boycott

Walmart’s revamps its shopping experience, announces Nike partnership

2. Apple unveils new chips, iPhones and watch

As part of the iPhone maker’s annual rollout of updated products, Apple AAPL, +2.42%  touted the new A12 Bionic chip, developed by the company and not Intel INTC, +1.42% or Advanced Micro Devices AMD, -5.37%  .

Here’s a summary of Apple coverage from the annual iPhone party on Wednesday:

Everything Apple just announced at its iPhone event

iPhone XR creates some drama for Apple’s new lineup

There’s now a $1,000 gulf between Apple’s cheapest and most expensive iPhones

Why would anybody buy the iPhone XS?

Apple Watch wants to monitor your heart’s health — and cardiologists say it could make you worry instead

3. Another anniversary — the 2008 financial crisis

Ten years after the credit crisis, Ray Dalio predicts the next financial crisis will be even worse.

Here’s more coverage of the crisis aftermath and predictions about the next one:

Nouriel Roubini: 10 reasons why conditions will be ripe for a financial crisis by 2020

These 4 called the last financial crisis. Here’s what they see causing the next one

Here’s what J.P. Morgan says could cause the next financial crisis

4. A contrarian stock play

Longtime Tesla TSLA, -0.37%  shareholders are used to volatility. But this time is different, according to Jeff Reeves, who makes the case for buying shares of another auto maker. GM, +0.56%  

5. Innocent until proven guilty, but investors need to learn how pump-and-dump schemes work

Teva Pharmaceuticals TEVA, +0.05% Chairman Phillip Frost has been accused of fraud by the Securities and Exchange Commission over an alleged scheme involving shares of Opko Health OPK, -18.01% which he also leads.

6. Surprising information about the U.S-China trade conflict

If you are worried about President Trump’s targeting of China on trade, read this.

7. Everyone should watch their sugar intake

It’s not only important for diabetics.

8. Tax tips for retirement planning

Here are three big tax mistakes to avoid as you plan for retirement.

9. Guess who’s competing with CRM, +1.81% dominates the market for customer-management software. But its up-and-coming competitor might surprise you.

10. Amazon’s Whole Foods purchase hasn’t changed the supermarket business — yet

A year after’s AMZN, -0.01%  purchase of Whole Foods, prices at the premium food retailer haven’t declined.

Want more from MarketWatch? Check out our Personal Finance Daily or other newsletters, and get the latest news, personal finance and investing advice.

Have this weekly roundup sent to your inbox. Subscribe to MarketWatch's free Weekly Roundup newsletter. Sign up here.

Be Sociable, Share!

Related Posts


MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.